Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study

Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study

OBJECTIVE: The present retrospective multicenter study aims at documenting characteristics of multiple myeloma (MM) patients and the effect of autologous stem cell transplant (ASCT) on survival. METHODS: A total of 134 adult patients initiating any new MM therapy from January 2002 till December 2019...

Full description

Bibliographic Details
Main Authors:	Fadi Nasr, Ahmad Al Ghoche, Saada Diab, Lewis Nasr, Emmanuel Ammanouil, Christelle Riachy, Souheil Hallit, Georges Chahine
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Leukemia Research Reports
Subjects:	transplant induction protocol progression free survival overall survival plasma cells disorder
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213048921000194

Similar Items

Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study
by: Shigeo Shimose, et al.
Published: (2022-09-01)

The Danish National Multiple Myeloma Registry
by: Gimsing P, et al.
Published: (2016-10-01)

The diagnostic and prognostic values of circulating miRNA-1246 in multiple myeloma
by: Guimin Zhao, et al.
Published: (2022-12-01)

Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study
by: Süleyman Şahin, et al.
Published: (2019-03-01)

A novel prognostic nomogram for patients with extragastric mucosa‐associated lymphoid tissue lymphoma: A multicenter study
by: Xiaoqian Li, et al.
Published: (2022-09-01)

Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study
by: Jian Hou, et al.
Published: (2017-07-01)

A prognostic model for patients with primary extramedullary multiple myeloma
by: Limei Zhang, et al.
Published: (2022-11-01)

Clinical Characteristics, Course, and Long-Term Outcomes in Patients with Talaromyces marneffei Infection: A 10-Year Retrospective Cohort Study
by: QingLiang Yu, et al.
Published: (2023-04-01)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
by: Giuseppe Fallara, et al.
Published: (2023-06-01)

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy
by: Xiaofei Zhu, et al.
Published: (2021-06-01)

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial
by: Ilaria Saltarella, et al.
Published: (2019-01-01)

Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma
by: I-Cheng Lee, et al.
Published: (2022-04-01)

Management of Recurrent Meningiomas: State of the Art and Perspectives
by: Marco Vincenzo Corniola, et al.
Published: (2022-08-01)

Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort
by: Irena Conic, et al.
Published: (2022-04-01)

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival
by: Ken Masubuchi, et al.
Published: (2022-10-01)

Efficacy and Safety Evaluation of Sintilimab for Cancer Treatment: A Systematic Review and Meta-analysis of Randomized Controlled Trials
by: Ziqi Ye, et al.
Published: (2022-04-01)

Long Non-Coding RNAs ASB16-AS1 and AFAP1-AS1: Diagnostic, Prognostic Impact and Survival Analysis in Colorectal Cancer
by: Elabd NS, et al.
Published: (2022-08-01)

Evaluation of Preoperative Inflammation-Based Prognostic Scores in Patients With Intrahepatic Cholangiocarcinoma: A Multicenter Cohort Study
by: Chaobin He, et al.
Published: (2021-06-01)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
by: Yang Li, et al.
Published: (2021-11-01)

Survival and Prognosis Analysis of Bortezomib Based Regimen in Newly Diagnosed Super-aged Multiple Myeloma Patients
by: ZHAO Fengyi, LI Xin, ZHAN Xiaokai, ZHANG Jiajia, SHEN Man, TANG Ran, FAN Sibin, HUANG Zhongxia
Published: (2024-03-01)

Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study
by: Marlies Antlanger, et al.
Published: (2018-10-01)

Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis
by: Yifeng Mao, et al.
Published: (2022-08-01)

Efficacy and Safety of Vaccines After Conventional Treatments for Survival of Gliomas: A Systematic Review and Meta-Analysis
by: Elnaz Amanzadeh Jajin, et al.
Published: (2024-04-01)

Results of pelvic exenteration in patients with cervical cancer: clinical experience
by: Golib A. Khakimov, et al.
Published: (2023-12-01)

Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience
by: Vladimir Vukomanovic, et al.
Published: (2024-01-01)

Erratum: Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience
by: Frontiers Production Office
Published: (2024-01-01)

Computed Tomography Based Radiomics as a Predictor of Survival in Ovarian Cancer Patients: A Systematic Review
by: Stefania Rizzo, et al.
Published: (2021-02-01)

Inflammatory Indexes as Prognostic Factors of Survival in Geriatric Patients with Hepatocellular Carcinoma: A Case Control Study of Eight Slovak Centers
by: Dominik Safcak, et al.
Published: (2022-07-01)

Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study
by: Fei Cao, et al.
Published: (2023-09-01)

Prognostic nomograms for gastric carcinoma after D2 + total gastrectomy to assist decision-making for postoperative treatment: based on Lasso regression
by: Yifan Li, et al.
Published: (2023-07-01)

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
by: Hisanaga K, et al.
Published: (2021-02-01)

Prostate-speciﬁc antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival
by: Alexandre Mendonça Macedo, et al.
Published: (2023-02-01)

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
by: Hailun Xie, et al.
Published: (2023-02-01)

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
by: Hisanaga K, et al.
Published: (2021-07-01)

The usefulness of progression-free survival in surgical treatment of lung metastases
by: Jarosław Religioni, et al.
Published: (2022-06-01)

Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study
by: Chunlong Huang, et al.
Published: (2021-01-01)

Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women
by: Jinsong Su, et al.
Published: (2019-01-01)

Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: a retrospective observational study
by: Xiaoli He, et al.
Published: (2020-05-01)

Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study
by: Qianhao Meng, et al.
Published: (2023-02-01)

Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)
by: Vadim V. Ptushkin, et al.
Published: (2022-08-01)